Yongshengbuluo Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
2
Yongshengbuluo General Information
Description
Developer of new immune cell and stem cell drugs based in Huangshan, China. The company specialises in gene editing, cell drug development, and clinical research.
Contact Information
Corporate Office
- Number 4-1, Huizhou Maple Leaf Residence, Qiankou Town
- Huizhou District
- Huangshan, Anhui
- China
Corporate Office
- Number 4-1, Huizhou Maple Leaf Residence, Qiankou Town
- Huizhou District
- Huangshan, Anhui
- China
Yongshengbuluo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 15-Apr-2025 | Completed | Generating Revenue |
Yongshengbuluo Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Jinhuifeng Investment Management | Growth/Expansion | Minority | ||
| Beijing Shengshi Hongming Investment Fund Management | Fund of Funds | Minority |
Yongshengbuluo FAQs
-
When was Yongshengbuluo founded?
Yongshengbuluo was founded in 2024.
-
Where is Yongshengbuluo headquartered?
Yongshengbuluo is headquartered in Huangshan, China.
-
What industry is Yongshengbuluo in?
Yongshengbuluo’s primary industry is Drug Discovery.
-
Is Yongshengbuluo a private or public company?
Yongshengbuluo is a Private company.
-
What is Yongshengbuluo’s current revenue?
The current revenue for Yongshengbuluo is .
-
Who are Yongshengbuluo’s investors?
Beijing Jinhuifeng Investment Management and Beijing Shengshi Hongming Investment Fund Management have invested in Yongshengbuluo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process